Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis

Blood

Volumn 101, Issue 10, 2003, Pages 3960-3968

  Kumar, Pawan ^b   Amin, Mohammad A ^b   Harlow, Lisa A ^b   Polverini, Peter J ^b   Koch, Alisa E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; COLLAGEN; ENZYME INHIBITOR; LAMININ; MORPHOLINE DERIVATIVE; PROTEOGLYCAN; RECOMBINANT PROTEIN;

ANGIOGENESIS; ARTICLE; BIOASSAY; BLOOD VESSEL; CONTROLLED STUDY; DRUG INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL CULTURE; CHEMOTAXIS; DRUG COMBINATION; DRUG EFFECT; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; SKIN; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; CHEMOTAXIS; CHROMONES; COLLAGEN; DRUG COMBINATIONS; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; LAMININ; MICROCIRCULATION; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SKIN; SRC-FAMILY KINASES; UMBILICAL VEINS;

EID: 0037589020     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-04-1237     Document Type: Article

References (42)

1. Eliceiri BP, Paul R, Schwartzberg PL, et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability, Mol Cell. 1999;4:915-924.
2. Jiang BH, Zheng JZ, Aoki M, et al. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A. 2000;97:1749-1753.
3. Kypta RM, Goldberg Y, Ulug ET, et al. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell. 1990;62:481-492.
4. Mori S, Ronnstrand L, Yokote K, et al. Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J. 1993;12:2257-2264.
5. Toker A, Cantley LC, Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997;387:673-676.
6. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318-1321.
7. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
8. Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A. 1987;84:9238-9242.
9. Chapman PT, Haskard DO. Leukocyte adhesion molecules. Br Med Bull. 1995;51:296-311.
10. x. Science. 1990; 250:1130-1132.
11. Lowe JB, Stoolman LM, Nair RP, et al. ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell. 1990;63:475-484.
12. x is recognized by the endothelial cell leu kocyte adhesion molecule ELAM-1. J Biol Chem. 1991;266:14869-14872.
13. Koch AE, Turkiewicz W, Harlow LA, et al. Soluble E-selectin in arthritis. Clin Immunol Immunopathol. 1993;69:29-35.
14. Hebbar M, Peyrat JP. Significance of soluble endothelial molecule E-selectin in patients with breast cancer. Int J Biol Markers. 2000;15:15-21.
15. Benekli M, Gullu IH, Tekuzman G, et al. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer. Br J Cancer. 1998;78:267-271.
16. Koch AE, Halloran MM, Haskell CJ, et al. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995;376:517-519.
17. Kumar P, Hosaka S, Koch AE. Soluble E-selectin induces monocyte chemotaxis through Src family tyrosine kinases. J Biol Chem. 2001;276:21039-21045.
18. Morel JC, Park CC, Zhu K, Kumar P, Ruth JH, Koch AE. Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J Biol Chem. 2002;277:34679-34691.
19. Volin MV, Harlow LA, Woods JM, et al. Treatment with sulfasalazine or sultapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum. 1999;42:1927-1935.
20. Passaniti A, Taylor RM, Pili R, et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest. 1992;67:519-528.
21. Johns A, Freay AD, Fraser W, et al. Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology. 1996;137:4511-4513.
22. Lijana RC, Williams MC. Tetramethylbenzidine - a substitute for benzidine in hemoglobin analysis. J Lab Clin Med. 1979;94:266-276.
23. Liem HH, Cardenas F, Tavassoli M, et al. Quantitative determination of hemoglobin and cytochemical staining for peroxidase using 3,3′,5,5′-tetramethylbenzidine dihydrochloride, a safe substitute for benzidine. Anal Biochem. 1979;98: 388-393.
24. Roche S, Koegl M, Courtneidge SA. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci U S A. 1994; 91:9185-9189.
25. Jacob CO, McDevitt HO. Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature. 1988;331:356-358.
26. Simon SI, Hu Y, Vestweber D,et al. Neutrophil tethering on E-selectin activates beta 2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J Immunol. 2000;164:4348-4358.
27. Hu Y, Kiely JM, Szente BE, et al. E-select-independent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells. J Immunol. 2000;165:2142-2148.
28. Chisholm LJ, Dovgan PS, Agrawal DK, et al. Modulation of monocyte adherence to endothelial cells by endothelin-1 involvement of Src (p60src) and JAK1-like kinases. J Vasc Surg. 1996;23: 288-300.
29. Klint P, Kanda S, Kloog Y, et al. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene. 1999;18: 3354-3364.
30. Wong BR, Besser D, Kim N, et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell. 1999;4:1041-1049.
31. Hiles ID, Otsu M, Volinia S, et al. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 1992;70:419-429.
32. Klippel A, Escobedo JA, Hu Q, et al. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol Cell Biol. 1993;13:5560-5566.
33. Thakker GD, Hajjar DP, Muller WA, et al. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem. 1999; 274:10002-10007.
34. Qiu Y, Robinson D, Pretlow TG, et al. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A. 1998;95:3644-3649.
35. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995;267:2003-2006.
36. Vara JA, Caceres MA, Silva A, et al. Src family kinases are required for prolactin induction of cell proliferation. Mol Biol Cell. 2001;12:2171-2183.
37. Abu-Ghazaleh R, Kabir J, Jia H, et al. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and antiapoptosis in endothelial cells. Biochem J. 2001; 360:255-264.
38. Mochizuki Y, Nakamura T, Kanetake H, et al. Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J Cell Sci. 2002;115:175-183.
39. Park CC, Morel JC, Amin MA, et al. Evidence of IL-18 as a novel angiogenic mediator. J Immunol. 2001;167:1644-1653.
40. Koch AE. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis. 2000;59:165-171.
41. Hartwell DW, Butterfield CE, Frenette PS, et al. Angiogenesis in P- and E-selectin-deficient mice. Microcirculation. 1998;5:173-178.
42. Aoki M, Kanamori M, Yudoh K, et al. Effects of vascular endothelial growth factor and E-selectin on angiogenesis in the murine metastatic RCT sarcoma. Tumour Biol. 2001;22:239-246.